<DOC>
<DOCNO>
EP-0015673
</DOCNO>
<TEXT>
<DATE>
19800917
</DATE>
<IPC-CLASSIFICATIONS>
C07C-209/00 <main>C07C-87/40</main> C07C-211/00 C07C-211/41 C07C-209/50 A61P-31/00 A61P-25/00 A61K-31/13 A61P-31/12 C07C-85/12 C07C-85/11 C07C-85/04 C07C-211/38 C07C-67/00 
</IPC-CLASSIFICATIONS>
<TITLE>
3-amino-4-homoisotwistane derivatives for use as antiviral agents, process for their preparation and compositions containing them.
</TITLE>
<APPLICANT>
kao corpjp <sep>sumitomo chemical cojp <sep>kao soap company, limited <sep>sumitomo chemical company limited<sep>kao corporation1-14-10, nihonbashikayaba-cho, chuo-kutokyojp<sep>sumitomo chemical company, limitedkitahama 4-chome 5-33chuo-ku osaka 541jp<sep>kao soap company, limited<sep>sumitomo chemical company, limited <sep>
</APPLICANT>
<INVENTOR>
atsumi toshio<sep>okahima hideki<sep>takebayashi yoshiaki<sep>atsumi, toshio<sep>okahima, hideki<sep>takebayashi, yoshiaki<sep>atsumi, toshio3-45, seiwadainishi-2-chomekawanishi-shijp<sep>okahima, hideki4-2-204, ryodochonishinomiya-shijp<sep>takebayashi, yoshiaki11-8-409, sonehigashimachi-2-chometoyonaka-shijp<sep>atsumi, toshio <sep>okahima, hideki  <sep>takebayashi, yoshiaki<sep>atsumi, toshio3-45, seiwadainishi-2-chomekawanishi-shijp<sep>okahima, hideki4-2-204, ryodochonishinomiya-shijp<sep>takebayashi, yoshiaki11-8-409, sonehigashimachi-2-chometoyonaka-shijp<sep>
</INVENTOR>
<ABSTRACT>
3-amino-4-homoisotwistane derivatives of the formula,    wherein r₁ is hydrogen or an alkyl or alkenyl group, and  r₂ is an alkyl or alkenyl group, or non-toxic pharmaceu­ tically acceptable salts thereof, are prepared by reacting a  3-r₁-amino-4-homoisotwistane with r₃x where r₃ is alkyl,  alkenyl, carboalkoxy or alkanoyl and x is halogeno and  reducing any carboalkoxy or alkanoyl group in the reaction  product to an alkyl group or are prepared by reacting 3-bro­ mo-4-homoisotwistane with r₁r₂nh.  the compounds and  salts, which can be formulated into pharmaceutical compo­ sitions, are valuable as antiviral agents for animals and  useful for the treatment of perkinsonean disease.  
</ABSTRACT>
</TEXT>
</DOC>
